Advanced search
Publication Cover
Biomarkers in Medicine Volume 1, 2007 - Issue 3
Submit an article Journal homepage
41
Views
0
CrossRef citations to date
0
Altmetric
Review

Repeated Assessment of Physical Biomeasures or Blood Biomarkers for the Definition of Volume Status and Cardiac Loading in LVSD

Marie Jennyfer Ng Kam Chuen1 University Department of Medicine,City Hospital,Dudley Road, Birmingham,B18 7QHEngland, UK.
,
Gregory YH Lip1 University Department of Medicine,City Hospital,Dudley Road, Birmingham,B18 7QHEngland, UK.
&
Robert J MacFadyen1 University Department of Medicine,City Hospital,Dudley Road, Birmingham,B18 7QHEngland, UK.Correspondence[email protected]
Pages 355-374 | Published online: 05 Nov 2007

Bibliography

  • Davies M , HobbsF, DavisR et al.: Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: a population based study. Lancet358(9280), 439–444 (2001).
  • Davis RC , HobbsFD, KenkreJE et al.: Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ325(7373), 1156 (2002).
  • Hobbs FD , RoalfeAK, DavisRC et al.: Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur. Heart J.28(9), 1128–1134 (2007).
  • Michalsen A , KonigG, ThimmeW: Preventable causative factors leading to hospital admission with decompensated heart failure.Heart80 , 437–441 (1998).
  • Androne AS , HryniewiczK, HudaihedA et al.: Relation of unrecognised hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am. J. Cardiol.93 , 1254–1259 (2004).
  • Drazner MH , RameJE, StevensonLW, DriesDL: Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure.N. Engl. J. Med345 , 574–581 (2001).
  • Eshaghian S , HorwichTB, FonarowGC: Relation of loop diuretic dose on mortality in advanced heart failure.Am. J. Cardiol.97 , 1759–1764 (2006).
  • MacFadyen RJ : Intraindividual temporal variance of biomarkers and the definition of individualized prognosis in cardiovascular patients.J. Hum. Hypertens.20 , 383–386 (2006).
  • Smith RF , JohnsonG, ZiescheS et al.: Functional capacity in heart failure. Circulation87(Suppl. VI) , VI88–VI93 (1993).
  • Wilson JR , RayosG, YeohTK et al.: Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation92 , 47–53 (1995).
  • Ennezat PV , EnnezatCA, VijayaramanP et al.: Dissociation between improvement in left ventricular performance and functional class in patients with chronic heart failure. J. Cardiovasc. Pharmacol.46(3), 262–268 (2005).
  • Drazner MH , RameJE, DriesDL: Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction.Am. J. Med.114(6), 431–437 (2003).
  • Stevenson LW , PerloffJK: The limited reliability of physical signs for estimating hemodynamics in chronic heart failure.JAMA261 , 884–888 (1989).
  • Butman SM , EwyGA, StandenJR et al.: Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distentsion. J. Am. Coll. Cardiol.22 , 969–974 (1993).
  • Hosenpud JD , BennettLE, KeckBM et al.: The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Report: 1999. J. Heart Lung Transplant.18 , 611–626 (1999).
  • Chakko S , WoskaD, MartinezH et al.: Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am. J. Med.90 , 353–259 (1991).
  • Marcus GM , MichaelsAD, De MarcoTet al.: Usefulness of the third heart sound in predicting an elevated level of B-type natriuretic peptide. Am. J. Cardiol.93 , 1312–1313 (2004).
  • Chomsky DB , LangCC, RayosG, WilsonJR: Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. J. Heart Lung Transplant.16(8), 846–853 (1997).
  • International Committee for Standardization in Hematology: Recommended methods for measurements of red-cell and plasma volume. J. Nucl. Med.21 , 793–800 (1980).
  • Anand IS , FerrariR, KalraGSet al.: oedema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation80 , 299–305 (1989).
  • Henning RJ , WelMH: Effect of afterload reduction on plasma volume during acute heart failure.Am. J. Cardiol.42 , 823–827 (1978).
  • James KB , McCarthyPM, JaaloukSet al.: Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation93 , 1515–1519 (1996).
  • Feigenbaum MS , WelschMA, MitchellMet al.: Contracted plasma and blood volume in chronic heart failure. J. Am. Coll. Cardiol.35 , 51–55 (2000).
  • Conway J , LauwersP: Hemodynamic and hypotensive effects of long term therapy with chlorothiazide.Circulation21 , 21–27 (1960).
  • Tarazi RC , DustanHP, FrohlichED: Long term thiazide therapy in essential hypertension: evidence for persistent alteration in plasma volume and renin activity.Circulation41 , 709–717 (1970).
  • Brown MA , MitarDA, WhitworthJA: Measurement of plasma volume in pregnancy.Clin. Sci.83 , 29–34 (1992).
  • Task Force Report: guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J.22 , 1017–1028 (2001).
  • Webel AR , FrazierSK, LennieTet al.: Daily variability in dyspnea, edema and body weight in heart failure patients. Eur. J. Cardiovasc. Nurs.6(1), 60–65 (2007).
  • Wright SP , WalshH, IngleyKMet al.: Uptake of self-management strategies in a heart failure management programme. Eur. J. Heart Fail.5(3), 371–380 (2003).
  • Godberg LR , PietteJD, WalshMNet al.: Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am. Heart J.146(4), 705–712 (2003).
  • Cleland JG , LouisAA, RigbyASet al.: Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J. Am. Coll. Cardiol.45(10), 1654–1664 (2005).
  • Lewin J , LedwidgeM, O‘LoughlinCet al.: Clinical deterioration in established heart failure: what is the value to BNP and weight gain in aiding diagnosis. Eur. J. Heart Fail.7(6), 953–957 (2005).
  • Hamilton WF , WoodburyRA, HaperHT: Arterial cerebrospinal and venous pressures in man during coughing and strain.Am. J. Physiol.14 , 42–50 (1994).
  • Felker GM , CuculichPS, GheorghiadeM: The Valsalva manoeuvre: a bedside ’biomarker‘ for heart failure.Am. J. Med.119 , 117–122 (2006).
  • Weilenmann D , RickliH, FollathFet al.: Non-invasive evaluation of pulmonary capillary wedge pressure by response to the Valsalva manoeuvre. Chest122 , 140–145 (2002).
  • Zema MJ , RestivoB, SosTet al.: Left ventricular dysfunction-bedside Valsalva manoeuvre. Br. Heart J.44(5), 560–569 (1980).
  • Brunner-La Rocca HP , WeilenmannD, RickliHet al.: Is blood pressure response to the Valsalva manoeuvre related to neurohormones, exercise capacity, and clinical findings in heart failure? Chest116 , 861–867 (1999).
  • McIntyre KM , VitaJA, LambrewCTet al.: A nonivasive method of predicting pulmonary capillary wedge pressure. N. Engl. J. Med.327 , 1715–1720 (1992).
  • Givertz MM , SlawskyMT, MoraesDLet al.: Non invasive determination of pulmonary artery wedge pressure in patients with chronic heart failure. Am. J. Cardiol.87(10), 1213–1215 (2001).
  • Sharma GVRK , WoodsPA, LambrewCTet al.: Evaluation of a non-invasive system for determinging left ventricular filling pressure. Arch. Intern. Med.162(18), 2084–2088 (2002).
  • Parisi AF , HarringtonJJ, AskenaziJet al.: Echocardiographic evaluation of the Valsalva manoeuvre in healthy subjects and patients with and without heart failure. Circulation54(6), 921–927 (1976).
  • Robertson D , StevensRM, FriesingerGCet al.: The effect of the Valsalva manoeuvre on echocardiographic dimensions in man. Circulation55(4), 296–362 (1977).
  • Little WC , BarrWK, CrawfordMH: Altered effect of the Valsalva manoeuvre on left ventricular volume in patients with cardiomyopathy.Circulation71(2), 227–233 (1985).
  • Binanay C , CaliffRM, HasselbladVet al.: Evaluation study of congestive heart failure and pulmonary artery catheterisation effectiveness: The ESCAPE trial. JAMA294(13), 1625–1633 (2005).
  • Drazner MH , HamiltonMA, FonarowGet al.: Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J. Heart Lung Transplant.18(11), 1126–1132 (1999).
  • Rohde LE , FurianT, CamposCet al.: Implications of the hemodynamic optimization approach guided by right heart catheterization in patients with severe heart failure. Arq. Bras. Cardiol.78(3), 261–266 (2002).
  • Steimle AE , StevensonLW, Chelimsky-FallickCet al.: Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation96 , 1165–1172 (1997).
  • Brock H , GabrielC, BiblDet al.: Monitoring intravascular volumes for postoperative volume therapy. Eur. J. Anaesthesiol.19(4), 288–294 (2002).
  • Oohashi S , EndohH: Does central venous pressure or pulmonary capillary wedge pressure reflect the status of circulating blood volume in patients after extended esophagectomy.J. Anesth.19(1), 21–25 (2005).
  • Diebel LN , WilsonRF, TagettMGet al.: End-diastolic volume. A better indicator of preload in the critically ill. Arch. Surg.127(7), 817–821 (1992).
  • Ohlsson A , NordlanderR, BennettTet al.: Continuous ambulatory hemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur. Heart J.19(1), 174–184 (1998).
  • Steinhaus DM , LemeryR, BresnahanDRJret al.: Initial experience with an implantable hemodynamic monitor. Circulation93(4), 745–752 (1996).
  • Ohlsson A , KuboSH, SteinhausDet al.: Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor. Eur. Heart J.22 , 942–954 (2001).
  • Braunschweig G , LindeC, ErikssonMJet al.: Continuous hemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur. Heart J.23 , 59–69 (2002).
  • Benett T , SharmaA, SuttonRet al.: Development of a rate adaptive pacemaker based on the maximum rate-of-rise of right ventricular pressure (RV dP/dtmax). Pacing Clin. Electrophysiol.15 , 219–234 (1992).
  • Reynolds DW , BarteltN, TaepkeRet al.: Measurement of pulmonary artery diastolic pressure from the right ventricle. J. Am. Coll. Cardiol.25 , 1176–1182 (1995).
  • Chuang PP , WilsonRF, HomansDCet al.: Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure. J. Card. Fail.2 , 41–46 (1996).
  • Braunschweig F , KjellstromB, SoderhallMet al.: Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantabe hemodynamic monitor. Nephrol. Dial. Transplant.21(1), 176–183 (2006).
  • Kjellstrom B , IgelD, AbrahamJet al.: Trans-telephonic monitoring of continuous hemodynamic measurements in heart failure patients. J. Telemed. Telecare11(5), 240–244 (2005).
  • Adamson PB , MagalskiA, BraunschweigFet al.: Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J. Am. Coll. Cardiol.41(4), 565–571 (2003).
  • Peacock WF IV , AlbertNM, KiesPet al.: Bioimpedance monitoring: better than chest x-ray for predicting abnormal pulmonary fluid?Congest. Heart Fail.6(2), 86–89 (2000).
  • Hannan WJ , CowenSJ, PlesterCEet al.: Comparison of bioimpedance spectroscopy and multi-freqeuncy bioimpedance analysis for the assessment of extracellular and total body water in surgical patients. Clin. Sci.89 , 651–658 (1995).
  • Charach G , RabinovichP, GrosskopfIet al.: Transthoracic monitoring of the impedance of the right lung in patients with cardiogenic pulmonary edema. Crit. Care Med.21(6), 1137–1144 (2001).
  • Noble TJ , MoriceAH, ChannerKSet al.: Monitoring patients with left ventricular failure by electrical impedance tomography. Eur. J. Heart Fail.1 , 379–384 (1999).
  • Packer M , AbrahamWT, MehraMRet al.: Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J. Am. Coll. Cardiol.47 , 2245–2252 (2006).
  • Noble TJ , HarrisND, MoriceAHet al.: Diuretic induced change in lung water assessed by electrical impedance tomography. Physiol. Meas.21(1), 155–163 (2000).
  • Paterna S , Di PasqualeP, ParrinelloGet al.: Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. J. Am. Coll. Cardiol.45 , 1997–2003 (2005).
  • Smye SW , SutcliffeJ, PittE: A comparison of four commercial systems used to measure whole-body electrical impedance.Physiol. Meas.14 , 473–478 (1993).
  • Yamamoto T , YamamotoY: Electrical properties of the epidermal stratum corneum.Med. Biol. Eng.14 , 151–158 (1976).
  • Yamamoto Y , YamamotoT: Characteristics of skin admittance for dry electrodes and measurement of skin moisturization.Med. Biol. Eng. Comput.24 , 71–77 (1986).
  • Stahl C , BeierleinW, WalkerTet al.: Assessing acute left ventricular volume changes by intracardiac impedance in a heart failure pig model. Circulation114(18 Suppl. S) , 373 (2006).
  • Ganion V , RhodesM, StadlerRW: Intrathoracic impedance to monitor heart failure status: a comparison of two methods in a chronic heart failure dog model.Congest. Heart Fail.11(4), 177–181 (2005).
  • Yu CM , WangL, ChauEet al.: Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation112(6), 841–848 (2005).
  • Maines M , CatazaritiD, CeminCet al.: Case–control study about the usefulness of intrathoracic fluids accumulation monitoring in the management of heart failure patients. Heart Rhythm Society, Scientific Sessions, May 19, Boston, MA, USA abstract AB48–4 (2006).
  • Shochat M , CharachG, MeylerSet al.: Internal thoracic impedance monitoring: a novel method for the preclinical detection of acute heart failure. Cardiovasc. Revasc. Med.7(1), 41–45 (2006).
  • Kumar A , AnelR, BunnellEet al.: Effect of large volume infusion on left ventricular volumes, performance and contractility parameters in normal volunteers. Intensive Care Med.30 , 1361–1369 (2004).
  • Volpe M , TrittoC, DeLucaNet al.: Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. Circulation86(6), 1800–1809 (1992).
  • Volpe M , RaoMAE, CuocoloAet al.: Radionulclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Effects of angiotensin converting enzyme inhibition. Circulation92(9), 2511–2518 (1995).
  • Nishimura RA , AppletonCP, RedfieldMM, IlstrupDM, HolmesDRJr, TajikAJ: Non- invasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterisation study. J. Am. Coll. Cardiol.28(5), 1226–1233 (1996).
  • Pozzoli M : Non-invasive evaluation of the hemodynamic profile in patients with heart failure: estimation of left atrial pressure.Ital. Heart J. Suppl.1(10), 1326–1333 (2000).
  • Tabata T , ThomasJD, KleinAL: Pulmonary venous flow by Doppler echocardiography: revisited 12 years later.J. Am. Coll. Cardiol.41 , 1243–1250 (2003).
  • Kuecherer HF , MuhiudeenIA, KusumotoFMet al.: Estimation of mean left atrial pressure from transesophageal pulsed Doppler echocardiography of pulmonary venous flow. Circulation82 , 1127–1139 (1990).
  • Rossvoll O , HatleLK: Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures.J. Am. Coll. Cardiol.21 , 1687–1696 (1993).
  • Gentile F , ManteroA, LippolisAet al.: Pulmonary vein flow velocity patterns in 143 normal subjects aged 20 to 80 years old. An echo 2D color Doppler co-operative study. Eur. Heart J.18 , 148–164 (1997).
  • Dokainish H , ZoghbiWA, LakkisNMet al.: Optimal non invasive assessment of left ventricular filling pressures. Circulation109 , 2432–2439 (2004).
  • Moreno FLL , HaganA, HolmenJR, PyrorA, StricklandRD, CastleCH: Evaluation of size and dynamics of the inferior vena cava as an index of right-sided cardiac function. Am. J. Cardiol.53 , 579–585 (1984).
  • Rein AJ , LewisN, ForstL, GotsmanMS, LewisBS: Echocardiography of the inferior vena cava in healthy subjects and in patients with cardiac disease.Isr. J. Med. Sci.18(5), 581–585 (1982).
  • Natori H , TamakiS, KiraS: Ultrasonographic evaluation of ventilatory effect on inferior vena caval configuration.Am. Rev. Respir. Dis.120(2), 421–427 (1979).
  • Cheriex EC , LuenissenKML, JanssenJHA, MooyJMV, van HooffJP: Echocardiography of the inferior vena cava is a simple and reliable tool for estimation of ’dry weight‘ in hemodialysis patients. Nephrol. Dial. Transplant.4 , 563–568 (1989).
  • Capomonella S , FeboO, CaporotondiAet al.: Non-invasive estimation of right atrial pressure by combined Doppler echocardiographic measurements of the inferior vena cava in patients with congestive heart failure. Ital. Heart J.1(10), 684–690 (2000).
  • Sasaki T , KuboT, MiyamotoT, KomamuraK, HiondaK, MiyatakeK: Clinical significance of measuring inferior vena cava dimension in patients with acute exacerbation of chronic heart failure. J. Cardiol.37(6), 309–313 (2001).
  • Basnight MA , GonzalezMS, KershenovichSC, ApletonCP: Pulmonary venous flow velocity: relation to hemodynamics, mitral flow velocity and left atrial volume and ejection fraction. J. Am. Soc. Echocardiogr.4 , 457–558 (1991).
  • Barclay JL , KruszewskiK, CroalBL, CuthbertsonBH, OhJK, HillisGS: Relation of left atrial volume to B-type natriuretic peptide levels in patients with stable chronic heart failure.Am. J. Cardiol.98 , 98–101 (2006).
  • Lang RM , BierigM, DevereuxRBet al.: Recommendations for chamber quantification. Eur. J. Echocardiogr.7 , 79–108 (2006).
  • Schabelman S , SchillerNB, SilvermanNH, PortsTA: Left atrial volume estimation by two-dimensional echocardiography.Cathet. Cardiovasc. Diagn.7 , 165–178 (1981).
  • Hirata T , WolfeSB, PoppRL, HelmanCH, FeigenbaunH: Estimation of left atrial size using ultrasound.Am. Heart J.78 , 43–52 (1969).
  • Di Donato M , MoriF, BarlettaG, DabizziRP, FantiniF: Effect of dextran infusion on left atrial size in normal subjects. Cardiology69 , 257–264 (1982).
  • Moe GW , Canepa-AnsonR, HowardRJ, ArmstrongPW: Sequential changes in atrial pressures, dimensions, and plasma atrial natriuretic factor concentrations during volume loading in hemodynamically normal human subjects.J. Lab. Clin. Med.117(6), 528–534 (1991).
  • Pritchett AM , JacobsenSJ, MahoneyDW, RodchefferRJ, BaileyKR, RedfieldMM: Left atrial volume as an index of left atrial size: a population based study.J. Am. Coll. Cardiol.41 , 1036–1043 (2003).
  • Maeda K , TsutamotoT, WadaA, HisangaT, KinoshitaM: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.Am. Heart J.135 , 825–832 (1998).
  • McFarlane SI , WinerN, SowersJR: Role of the natriuretic peptide system in cardiorenal protection.Arch. Intern. Med.163 , 2696–2704 (2003).
  • Troughton RW , FramptonCM, YandleTGet al.: Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet355(9210), 1126–1130 (2000).
  • Richards AM , LainchburyJG, NichollsMGet al.: BNP in hormone-guided treatment of heart failure. Trends Endocrinol. Metab.13(4), 151–155 (2002).
  • Corboy JC , WalkerRJ, SimmondsMBet al.: Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. Clin. Sci. (Lond.)87(6), 679–684 (1994).
  • Heringlake M , HeideC, BahlmannLet al.: Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. J. Appl. Physiol.97(1), 173–179 (2004).
  • James KB , TroughtonRW, FeldschuhJet al.: Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study. Am. Heart J.150(5), 984 (2005).
  • Volpe M , TrittoC, De LucaNet al.: Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. Eur. J. Clin. Invest88 , 1481–1489 (1991).
  • Uretsky BF , VerbalisJG, MuraliSet al.: Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. J. Clin. Endocrinol. Metab.71 , 146–151 (1990).
  • Rodeheffer RJ , MillerWL, BurnettJCJr: Atrial natriuretic factor release is augmented by leg elevation in human subjects with congestive heart failure. J. Am. Coll. Cardiol.17 , 316a (Abstract) (1991).
  • Braunschweig F , Fahrleitner-PammerA, MangiavacchiMet al.: Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure. Eur. J. Heart Fail.8(8), 797–803 (2006).
  • Chuen MJNK , MacFadyenRJ: Variable etiologies contributing to the anemia of systolic heart failure are important to individual patient management.Eur. Heart J.28(2), 143–145 (2007).
  • Kosiborod M , CurtisJP, WangYet al.: Anemia and outcomes in patients with heart failure: a study form the National Heart Care Project. Arch. Intern. Med.165(19), 2187–2144 (2005).
  • Androne AS , KatzSD, LundLet al.: Hemodilution is common in patients with advanced heart failure. Circulation107 , 226–229 (2003).
  • Hogenhuis J , VoorsAA, JaarsmaTet al.: Low prevalence of B-type natriuretic peptide levels <100 pg/mL in patients with heart failure at hospital discharge. Am. Heart J.151(5), 1012.e1–e5 (2006).
  • Muscari A , BerzigottiA, BianchiGet al.: Non-cardiac determinants of NT-pro BNP levels in the elderly: relevance of hematocrit and hepatic steatosis. Eur. J. Heart Fail.8(5), 468–476 (2006).
  • Das SR , DriesDL, DraznerMHet al.: Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfucniton Prevention trial). Am. J. Cardiol.96(6), 827–831 (2005).
  • Jacobson LO , GoldwasserE, FriedWet al.: Role of kidney in erythropoiesis. 1957. J. Am. Soc. Nephrol.11(3), 589–590 (2000).
  • Volpe M , TrittoC, TestaUet al.: Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am. J. Cardiol.74 , 468–473 (1994).
  • Boyle A , SobotkaPA: Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate.J. Cardiac Fail.12(4), 247–249 (2006).
  • Schroeder KL , SallustioJE, RossEA: Continuous hematocrit monitoring during intra-dialytic hypotension: precipitous decline in plasma refill rates.Nephrol. Dial. Transplant.19(3), 652–656 (2004).
  • Felker GM , AdamsKFJr, GattisWAet al.: Anemia as a risk factor and therapeutic target in heart failure. J. Am. Coll. Cardiol.44 , 959–966 (2004).
  • Schrier RW , AbrahamWT: Mechanisms of disease – hormones and hemodynamics in heart failure.N. Eng. J. Med.341 (8) , 577–585 (1999).
  • Horwich TB , PatelJ, MacLellanWRet al.: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation108(7), 833–838 (2003).
  • Gheorghiade M , AbrahamWT, AlbertNMet al.: Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE–HF registry. Eur. Heart J.28 , 980–988 (2007).
  • Hamaad A , LipGYH, MacFadyenRJ: Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?Eur. J. Heart Fail.6(6), 683–686 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.